全文获取类型
收费全文 | 1517篇 |
免费 | 149篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 20篇 |
妇产科学 | 18篇 |
基础医学 | 111篇 |
口腔科学 | 76篇 |
临床医学 | 128篇 |
内科学 | 446篇 |
皮肤病学 | 21篇 |
神经病学 | 68篇 |
特种医学 | 41篇 |
外科学 | 170篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 69篇 |
眼科学 | 73篇 |
药学 | 91篇 |
中国医学 | 4篇 |
肿瘤学 | 298篇 |
出版年
2024年 | 3篇 |
2023年 | 27篇 |
2022年 | 43篇 |
2021年 | 60篇 |
2020年 | 46篇 |
2019年 | 73篇 |
2018年 | 73篇 |
2017年 | 64篇 |
2016年 | 69篇 |
2015年 | 76篇 |
2014年 | 80篇 |
2013年 | 101篇 |
2012年 | 145篇 |
2011年 | 128篇 |
2010年 | 90篇 |
2009年 | 79篇 |
2008年 | 88篇 |
2007年 | 86篇 |
2006年 | 95篇 |
2005年 | 54篇 |
2004年 | 52篇 |
2003年 | 53篇 |
2002年 | 37篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 4篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1929年 | 1篇 |
排序方式: 共有1673条查询结果,搜索用时 31 毫秒
41.
Farid R Farid F Ghaffari J Jabbari F Rahimzadeh M 《Iranian journal of allergy, asthma, and immunology》2003,2(4):193-196
Although response to intranasal steroid therapy has been reported in patients with allergic rhinitis, efficacy of some nasal steroids is noteworthy.This study was undertaken to evaluate the efficacy of a two-week course of Fluticasone (Flixonase) nasal spray vs. Beclomethasone (beconase) nasal spray in patients with symptoms of allergic rhinitis referred to our clinic. This study reviewed sixty randomized studies with symptoms of allergic rhinitis which supported common aeroallergens with skin prick test. Patients received a total daily dose of nasal spray of Fluticasone (Flixonase) 100 mcg bid (N=30) compared with patients with allergic rhinitis who received a total daily dose of Beclomethasone (Beconase) 50mcg 2 puffs bid (N=30). Patients were visited before and after therapy, and efficacy of Flixonase and Beconase was evaluated by the change in nasal symptoms including: nasal discharge, nasal obstruction, nasal itching, and sneezing. After two weeks of treatment nasal symptoms of blockage, discharge, sneezing and itching were significantly better in the group treated with Fluticasone nasal spray (65%, 82%, 67%, 79% respectively (p<0.001) but after treatment with beconase nasal spray lower benefits in the nasal symptoms includes: 50%, 71%, 51%, 57% respectively. After two weeks of treatment no deleterious changes consequent to therapy were observed in nasal symptoms. 100 mcg bid Flixonase (Fluticasone) intranasal spray is more effective than 50 mcg 2 puffs bid Beconase (Beclomethasone) intranasal spray. Like asthma, allergic rhinitis is an inflammatory disease and should be managed with anti-inflammatory medication. 相似文献
42.
Bradley D. Ashman Gerard P. Slobogean Trevor B. Stone Darius G. Viskontas Farhad O. Moola Bertrand H. Perey Dory S. Boyer Robert G. McCormack 《Injury》2014
Background
Operative fixation of displaced, mid-shaft clavicle fractures has become an increasingly common practice. With this emerging trend, data describing patient outcomes with longer follow-up are necessary.Patients and Methods
We retrospectively reviewed the medical records of subjects treated with plate fixation for displaced mid-shaft clavicle fractures from 2003 to 2009 at a Level I trauma hospital. All subjects were greater than 12 months post-index surgery. Treatment involved ORIF with either a low-contact dynamic compression plate (LCDC) or a contoured plate (pre-contoured or pelvic reconstruction plate). Our primary outcome was reoperation for any indication.Results
143 subjects were included. The mean age was 36 ± 14 years and the mean time to reoperation or chart review was 33 months. Contoured plates were used in 64% of cases and LCDC plates were used in the remaining subjects. Twenty-nine subjects (20%) underwent reoperation: 23.5% of subjects treated with LCDC plates and 18.5% of subjects treated with contoured plates (p = 0.52). Indications for reoperation included implant irritation (n = 25), implant failure (n = 2), and non-union (n = 2). There was near statistically significant association with reoperation and female gender (p = 0.05) but no association between reoperation and age (p = 0.14), fracture class (p = 0.53), plate type (p = 0.49), or plate location (p = 0.93). The mean QuickDASH score for the population surveyed was 8.8 (5.5–12.1; 95% CI) with near statistically significant and clinically relevant difference between those considering reoperation and those not 22.3 (8.6–36.0; 95% CI) versus 6.7 (3.6–9.8; 95% CI).Conclusions
This study represents a large series of displaced clavicle fractures treated with open reduction and plate fixation. Reoperation following plate fixation is relatively common, but primarily due to implant irritation. No difference in reoperation rates between plate types or location could be detected in our current sample size. Also, excellent functional outcomes continue to be observed several years after clavicle fracture fixation. 相似文献43.
Farhad Vahidi 《Journal of prosthodontics》2019,28(7):737-742
Pseudo class III malocclusion is reverse anterior occlusion or anterior cross‐bite with first molars and canines in a class I relationship. It is very important to diagnose the pseudo class III from true skeletal class III. The combination of anterior displacement of the mandible, tooth wear, and loss of occlusal vertical dimension (OVD) in adults may result anterior cross‐bite. The key factor in diagnosis of this malocclusion is an interdisciplinary approach with an orthodontist. Cephalometric images are essential for diagnosis of pseudo class III mal‐occlusion. Most relevant publications on correcting this condition have recommended either full‐coverage restorations or extraction and placement of implants to correct this malocclusion. Advances of material and technology may help dental practitioners to restore tooth wear and OVD with a conservative approach without removing more tooth structures. This clinical report shows the treatment of pseudo class III with minimally invasive treatment using partial coverage restorations fabricated with lithium disilicate. 相似文献
44.
Farhad Tabatabaian 《Journal of prosthodontics》2019,28(3):276-287
Monolithic zirconia restoration is an acceptable treatment option in restorative dentistry and a developing trend in esthetic dentistry. Digital dentistry has simplified fabrication of monolithic zirconia restorations. Zirconia ceramic has introduced an opportunity to achieve both esthetic and mechanical requirements for restorations. This is rarely found for a ceramic in dentistry. Monolithic zirconia restorations represent an acceptable durability, comparable to metal‐ceramic restorations, while they are superior to metal‐ceramic restorations esthetically; however, difficulties to gain an optimal shade reproduction and a color match with monolithic zirconia restorations still remain. The color of these restorations may be influenced by manufacturing processes, laboratory procedures, and clinical factors. Manufacturing processes determine basic optical properties of zirconia ceramics. Different laboratory procedures may create optical changes in zirconia ceramics. Also clinical factors such as dental background, cement, and zirconia restoration features may affect the resulting color. This literature review aimed to discuss potent factors in the color of monolithic zirconia restorations. An electronic search of the PubMed/Google Scholar database was performed to find related English‐language articles published between January 1, 2000, and October 31, 2017. The key terms of background, cement, ceramic, color, esthetics, shade, spectrophotometry, thickness, translucency, and zirconia were used both individually and simultaneously. Also, a manual search was conducted, and five classic articles of color science were added. Thus 192 articles were included. In the last decade, shade reproduction of monolithic zirconia restorations has been highly regarded; however, further improvements are required in the manufacturing process to produce tooth‐like zirconia ceramics. An esthetic guideline named background‐cement‐ceramic color harmony was suggested in this study; however, more clinical practice guidelines should be established for monolithic zirconia restorations on esthetics, and therefore, more studies are required. 相似文献
45.
46.
Yasmin Abaza Hagop Kantarjian Yasmin Alwash Gautam Borthakur Richard Champlin Tapan Kadia Guillermo Garcia-Manero Naval Daver Farhad Ravandi Srdan Verstovsek Jan Burger Zeev Estrov Maro Ohanian Miranda Lim Naveen Pemmaraju Elias Jabbour Jorge Cortes 《American journal of hematology》2020,95(11):1288-1295
Treatment of advanced-phase chronic myeloid leukemia (CML) remains unsatisfactory. Single-agent tyrosine kinase inhibitors have modest and short-lived activity in this setting. We conducted a phase I/II study to determine safety and efficacy of the combination of dasatinib and decitabine in patients with advanced CML. Two different dose schedules were investigated with a starting decitabine dose of either 10 mg/m2 or 20 mg/m2 daily for 10 days plus dasatinib 100 mg daily. The target dose level was decitabine 10 mg/m2 or 20 mg/m2 daily for 10 days plus dasatinib 140 mg daily. Thirty patients were enrolled, including seven with accelerated-phase CML, 19 with blast-phase CML, and four with Philadelphia-chromosome positive acute myeloid leukemia. No dose-limiting toxicity was observed at the starting dose level with either schedule. Grade ≥3 treatment emergent hematological adverse events were reported in 28 patients. Thirteen patients (48%) achieved a major hematologic response and six (22%) achieved a minor hematologic response, with 44% of these patients achieving a major cytogenetic response and 33% achieving a major molecular response. Median overall survival (OS) was 13.8 months, with significantly higher OS among patients who achieved a hematologic response compared to non-responders (not reached vs 4.65 months; P < .001). Decitabine plus dasatinib is a safe and active regimen in advanced CML. Further studies using this combination are warranted. 相似文献
47.
Maro Ohanian Hagop M. Kantarjian Mahran Shoukier Sara Dellasala Arine Musaelyan Graciela M. Nogueras Gonzalez Elias Jabbour Lynne Abruzzo Srdan Verstovsek Gautam Borthakur Farhad Ravandi Guillermo Garcia-Manero Gevorg Tamamyan Richard Champlin Sherry Pierce Alessandra Ferrajoli Tapan Kadia Jorge E. Cortes 《American journal of hematology》2020,95(10):1127-1134
We aimed to describe the impact of time to response on the outcomes of 75 patients with accelerated-phase chronic myeloid leukemia (CML-AP) at diagnosis. Patients had at least 1 feature of AP: blasts ≥15% (n = 2), basophils ≥20% (n = 19), platelets <100 × 109/L (n = 7), cytogenetic clonal evolution (n = 34), or more than one factor (n = 13). Thirty-three patients received imatinib; 42 received a second-generation tyrosine kinase inhibitor (2GTKI) (19 dasatinib and 23 nilotinib). We used chi-square and Kaplan-Meier analyses to determine the impact of various degrees of molecular and cytogenetic response at early time points (3 and 6 months) on rates of overall cytogenetic and molecular response, overall survival (OS), event-free survival (EFS), transformation-free survival (TFS), and failure-free survival (FFS). After a median follow-up of 96 months (range: 18-224 months), the overall rate of complete cytogenetic response was 79%, of major molecular response, 71%, and of molecular reponse (MR)4.5, 59%. Patients who achieved a major cytogenetic response (MCyR) (n = 49) at 3 months had significantly better 3-year OS (94% vs 75%; P = .002), TFS (98% vs 73%; P < .001), EFS (93% vs 42%; P < .001), and FFS (83% vs 25%; P < .001) rates than patients who did not have MCyR at 3 months. Most (67%) who eventually achieved sustained MR4.5 had achieved MCyR at 3 months. In de novo CML-AP, early response at 3 and 6 months is a strong determinant of long-term outcome. 相似文献
48.
Arash Khaki Amir Afshin Khaki Laleh Hajhosseini Farhad Sadeghpour Golzar Nava Ainehchi 《African journal of traditional, complementary, and alternative medicines》2014,11(4):1-8
Background
Diabetes rats have been linked to reproductive dysfunction and plant medicine has been shown to be effective in its treatment. Antioxidants have distinctive effects on spermatogenesis, sperm biology and oxidative stress, and changes in anti-oxidant capacity are considered to be involved in the pathogenesis of chronic diabetes mellitus. Ginger and cinnamon are strong anti-oxidants and have been shown to reduce oxidative stress in the long-term treatment of streptozotocin (STZ)-induced diabetes in animal models. The present study examined the influence of combined ginger and cinnamon on spermatogenesis in STZ-induced diabetes in male Wistar rats.Materials and Methods
Animals (n = 80) were allocated randomly into eight groups, 10 each: Group 1: Control rats given only 5cc Normal saline (0.9% NaCl) daily;Group2: rats received ginger (100mg/kg/rat) daily; Group 3: rats received cinnamon (75mg/kg) daily; Group 4: rats received ginger and cinnamon, (100mg/kg/rat ginger and 75mg/kg cinnamon) daily; Group 5: Diabetic control rats received only normal saline. Group 6: Diabetic rats received 100mg/kg/day ginger; Group 7: Diabetic rats received 75mg /kg/ day cinnamon; Group 8: Diabetic rats received ginger and cinnamon (100mg/kg/day and 75mg/kg /day). Diabetes was induced with 55 mg/kg, single intra-peritoneal injection of STZ in all groups. At the end of the experiment (56th day), blood samples were taken for determination of testosterone, LH,FSH, total anti-oxidant capacity, and levels of malondialdehyde, SOD, Catalase and GPX. All rats were euthanized, testes were dissected out and spermatozoa were collected from the epididymis for analysis.Results
Sperm numbers, percentages of sperm viability and motility, and total serum testosterone increased in ginger and cinnamon and combined ginger and cinnamon treated diabetic rats compared with control groups. Serum testosterone, LH and FSH were higher compared to control group and also serum anti-oxidants (TAC, SOD, GPX and catalase) all were increased at the end of treatment. Combined ginger and cinnamon showed more intense increase in all parameters compare to ginger and cinnamon alone. Most of the results were significant (P<0.05).Conclusion
We concluded that combined ginger and cinnamon have significant beneficial effects on the sperm viability, motility, and serum total testosterone, LH,FSH and serum anti-oxidants'' level and could be effective for maintaining healthy sperm parameters and male reproductive function in diabetics. 相似文献49.
50.
Behtash N Nazari Z Fakhrejahani F Khafaf A Azar EG 《The Australian & New Zealand journal of obstetrics & gynaecology》2007,47(1):46-49
BACKGROUND: Atypical glandular cell (AGC) on Pap smear is uncommon but may represent a variety of benign and malignant lesions. AIM: The aim of this study was to evaluate the association between AGC on Pap smear and significant pathological finding to tailor management protocols. METHODS: Between 2002 and 2005, 60 women with AGC on Pap smears were referred to our colposcopy clinic. Forty-one women underwent colposcopy-directed biopsy, endocervical curettage, endometrial sampling and cervical conisation to determine the cytological and histological correlations of AGC on Pap smears. RESULTS: The mean age of the patients was 46.9 +/- 11.5 years (range, 23-80 years). Of these patients 13 patients (31.7%) were postmenopause and 28 patients (68.2%) were in reproductive age. We found eight (19.5%) significant pathological findings including four (9.7%) high-grade squamous intraepithelial lesion, one (2.4%) adenocarcinoma of uterus, one (2.4%) adenocarcinoma of cervix, one (2.4%) squamous cell carcinoma of cervix and one (2.4%) papillary serous tumour of ovary. CONCLUSION: AGC on Pap smear was associated with a clinically significant diagnosis in approximately 20% of our cases. The women with a diagnosis of AGC on cervicovaginal smear are needed to be evaluated at least with colposcopy, endocervical and endometrial curettage. Clinicians should be careful about the significance of AGC on Pap smears. 相似文献